chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 inch diameter red rash around injection site, that was warm and itchy. It lasted about 5 days, but came back after I was out in the sun 10 days after the vaccination. That was gone after a day and after applying allergy cream.
He got his vaccine, after 2 1/2 days he was still having flu-like symptoms.  On 10/15/23 he started having discomfort under his arms, groin and the back of his throat.  The next 3-4 days he felt the discomfort go down to his throat area where his Adams apple was.  He was having problems with swallowing and eating soft things not to irritate it.  On 10/26/23 he went to the ER and they did a COVID swash, tested for strep, which both were negative.  Then his doctor since that area was larger than usual and showed that he had inflammation of the larynx and his eating was due to GERD.  They told him to rest his voice.  About the 29th or 30th everything went away except his right tonsil was pinkish in color, and was uncomfortable when he tried to swallow and lasted for about 10 days.  The irritation finally went away this past Friday, 11/17/23.   He is able to eat and swallow now without any problems.
This spontaneous report as received from a pharmacist regarding a 39 year old male patient. Current conditions and medical history were not reported. On an unknown date the patient started the therapy with MMR II. On 06-AUG-2014 the patient was vaccinated with MMR II lot # H014649, subcutaneous in the left arm. Concomitant medications were not reported. On 06-AUG-2014, after the injection, the pharmacist realized that the vaccine had expired on 03-Aug-2014 (also reported as 06-AUG-2014). At the time of reporting the patient did not experience any adverse events. The outcome of receiving expired vaccine was unknown. Causal relation of the event with the suspect drug was not reported. At the time of reporting it was unknown if the patient would continue to take MMR II. Additional information has been requested.
Patient stated that 2 days after her first shot, she experienced some weakness, numbness and tingling in her left leg. She did not let us know that she had this reaction until she came back to get her 2nd dose. She went to an urgent care thinking it was a pinched nerve. They gave her steroids, but she still has the issue and stated it was affecting her right-side some now as well. She limps a little bit and has some weakness. I reached out to Pfizer to see if they had any reports of numbness from their COVID vaccine. They stated they did not and could not provide any recommendations. On the chance this was related to the vaccine, I chose not to administer the 2nd dose.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 18-SEP-2014, the patient was vaccinated with ZOSTAVAX lot # J001009, expiration date 24-APR-2014, 0.65 ml, subcutaneous. On 18-SEP-2014, the patient was administered an expired dose of ZOSTAVAX. No adverse events were reported. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
I developed a cough and sore throat, on May 29, 2022 I took home COVID-19 Test that was positive. I called the doctors office spoke to doctor who prescribed Paxlovid that I am currently taking. After a couple days on the Paxlovid I no longer have a sore throat and have much less coughing than before.
2 hrs after he received his vaccine he experienced a sore arm  - shaking - chills - and a temp of 101. I gave him Tylenol.  He received his vaccine on a Wednesday.   Thursday - He experienced Chills - a temp of 103.4 - nose bleeds and spitting up blood.  Clots of blood coming from his nose and exhausted.  I continued with the Tylenol for the fever Friday - A temp of 100 - his arm still sore - exhausted - very little nose bleeds.  By evening time - low grade temp  - nose bleeds had stopped - exhausted. Continued with Tylenol.   Saturday - just exhausted and sore arm
Patient fully vaccinated with Moderna. Tested positive for Covid 19 on 12/7/2021. Patient was hospitalized at medical center on 01/14/2022. Expired on 01/14/2022 while still hospitalized.
High heart rate; high blood pressure; swollen tongue; trip to the Ear for observation; This is a spontaneous report from a contactable consumer (patient).   A 44-years-old non-pregnant female patient received first dose of BNT162B2(Formulation: Solution for injection; Batch/Lot number: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 07Mar2021 09:00 AM (at the age of 44 years) as 1ST DOSE SINGLE for covid-19 immunisation. Medical history included multiple sclerosis from an unknown date and unknown if ongoing. Known allergies with Stevia, penicillin, and sulfa sclerosis from an unknown date and unknown if ongoing. Concomitant medication included naltrexone (NALTREXONE) 3 mg taken for an unspecified indication, start and stop date were not reported. On 07Mar2021 09:15 AM patient experienced high heart rate, high blood pressure, swollen tongue and trip to the Ear for observation. 25 mg of benedryl given orally and released an hour later. The events resulted in doctor or other healthcare professional office/clinic visit since the vaccination, patient has not been tested for covid-19. The outcome of the events was resolving.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Redness, discoloration, swelling, rash, hotness, itching , and a new mole appeared.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant medication was not reported. On 30-OCT-2015 the patient was inadvertently vaccinated with ZOSTAVAX (lot # K007989 with expiration date of 15-SEP-2015; strength, dosage, frequency and route unspecified) (expired product administered). No adverse effects were reported. Additional information is not expected as the reporter did not want to be contacted.
cold sore; This is a spontaneous report from a contactable consumer (patient). A 41-years-old male patient received bnt162b2 (Solution for injection, lot number: unknown) via an unspecified route of administration in left arm on 09Feb2021 at 15:30 as 2nd dose, single dose for covid-19 immunisation. Medical history included PCN (penicillin) allergy and covid-19 from an unknown date and unknown if ongoing. Concomitant medication included duloxetine hydrochloride (CYMBALTA) and sildenafil citrate (VIAGRA). No other vaccine was received in four weeks. The patient previously received first dose of bnt162b2 for covid-19 immunisation. Covid tested post vaccination was reported as no. Patient reported that after his first vaccine, two days later he noticed that he had a cold sore. Patient was not concerned and on 12Feb2021 at 05:00 am, after the second vaccine experienced his face broke out all over with over five separate sites containing cold sores. Treatment received for the adverse events with topical ointment to put on the cold sores. The outcome of the event was not resolved.  Information on the lot/ batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Day 1 = Chills Day 2 = Body Aches and Fatigue Day 3 = Rash on the Right side of my Face & Left Lower Neck & Chin.  I made an appt with my Dr.  I went in for a visit and she diagnosed me with a Mild Case on the Shingles (and prescribed me two treatments for it).  Further, my Dr. says that I am the 2nd patient she has treated for Shingles shortly after receiving the J & J vaccine.
This spontaneous report was received from a Nurse refers to a 4 year old patient. On 20-MAR-2014, the patient was vaccinated with improperly stored VARIVAX (Merck) Lot # H014074 (dose, route and frequency were not reported). The nurse reported that on 24-OCT-2013, VARIVAX (Merck) was stored for -13.9 C for 8 hours. On 29-OCT-2013, the VARIVAX (Merck) was stored for -12.8 C for 4 hours. On 14-NOV-2013, the VARIVAX (Merck) was stored for -11.4 C for 1.5 hours. On 26-MAR-2014, the VARIVAX (Merck) was stored for -14.7 C for 1.5 hours. On 14-MAY-2014, the VARIVAX (Merck) was stored for -13.8 C for a total of 5 hours. Since the overall average for VARIVAX (Merck) was below -15 C, these cumulative excursions of -11.4C for 20 hours is supported. No adverse effect has been reported. No further information was provided. This case is linked to the case 1405USA015833, 1405USA0015834, 1405USA015835, 1405USA015836, 1405USA015837, 1405USA015839, 1405USA015840, 1405USA015841, 1405USA015842 and 1405USA008798 (same reporter link). Additional information has been requested.
Pulmonary Embolism Johnson & Johnson- 3/14/21 Pfizer Booster 10/24/21
pt was admitted on 6/19 with DKA, metabolic acidosis, severe oral thrush and non healing ear lesions secondary to new onset type 1 diabetes. she has had no recent illnesses or infections. she takes no medications and has no known medical problems. she sees her primary care regularly and never had problems with her blood sugars before. she is very active and eats well. she has never smoked. she noticed about 2 months ago not feeling herself. she noticed 2 scabs and sores on the outside of her ears that would not heal and sudden weight loss. she then noticed polydipsia, polyuria and polyphagia and thrush in her mouth. she went to urgent care on 6/19 and her blood sugar was 474 and she was directed to the ER for evaluation where she was found to be in DKA with new type 1 diabetes and admitted to the icu on an insulin drip. She had her covid 19 vaccines on 3/3 and 3/31. No hx illnesses or infections. she takes no medications. she has never had covid 19 to her knowledge. with iv fluids, insulin and treatment for her thrush her blood sugars were better controlled and she was transferred out of the icu to the medical floor for further education on management of new diabetes and placed on lantus, humalog with meals and sliding scale. she was seen by the diabetes educator and will be following up with endocrinology after discharge. autoimmune antibody panel for LADA pending.
majority of upper arm very red and warm.  Patient states she came down with a fever of 103 the following day and was diagnosed with cellulitis at the hospital where she revceived IV antibiotics
Per patient statement, they received the J&J vaccine but cannot recall date.  Has not yet received the booster.
Raised  itchy rash on neck and in corners of both eyes. On second day started antihistamine ( Claritin) .
Hives- on face and all over body. Often at night, first started in the afternoon on warm day. Warm water baths tend to trigger them.
Initial unsolicited report received from non-healthcare professional on 27 April 2015. This case is linked with case ID: 2015SA056122, 2015SA056123 (same vaccine). A patient (Demographics: unknown), whose medical history and concomitant medications were not reported, had received a dose of DAPTACEL (batch number: C4751AA, expiry date: 9 June 2017) via intramuscular route on April 2015. On unspecified date in April 2015, on the same day of vaccination the patient experienced large pink swelling, mild itching, area became red and hot to touch, Swelling was the size of golf ball. Patient required ER visit. Patient was treated with prednisone. Laboratory investigations were not reported. Upon medical review, the case was considered as serious due to important medical event: vaccination site inflammation and Vaccination site pruritus. At the time of the report, the outcome of the event was unknown. List of Documents held by Sender: None. Sender's Comments: Large injection site reactions including inflammation and pruritus are listed with DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE. This case is not sufficiently documented. More information on the vaccination technique and exploring alternate etiologies like trauma, insect bite etc. would be helpful to further assess this case. Based on the information provided, the role of vaccine cannot be assessed.
15 year old patient administered 1st Moderna dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st Moderna dose). On 05-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st Moderna dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  The treatment information was not provided.
Decreased alertness; This serious case was reported by a physician and described the occurrence of alertness decreased in a infant female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   The patient's past medical history included congenital aortic stenosis (on 07-NOV-2022), prematurity (on 07-NOV-2022, 36 weeks gestation), congenital mitral stenosis (on 07-NOV-2022), aortic coarctation (on 07-NOV-2022) and secondary hypertension (on 07-NOV-2022).   On an unknown date, the patient received Pediarix. On an unknown date, an unknown time after receiving Pediarix, the patient experienced alertness decreased (Verbatim: Decreased alertness) (serious criteria GSK medically significant). The outcome of the alertness decreased was not reported.   It was unknown if the reporter considered the alertness decreased to be related to Pediarix and Pediarix Pre-Filled Syringe Device.  It was unknown if the company considered the alertness decreased to be related to Pediarix and Pediarix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient: US2023031103, US2023AMR044927   Additional Information: GSK Receipt Date: 21-MAR-2023 The reporter reported that on 10 February 2023, the patient was scheduled to receive a dose of Pediarix alone as part of her 4 month vaccine series.  She had decreased alertness after her two-month vaccines, so patient's mom had requested to get each of the 4 month vaccines on separate days. She had scheduled for a nurse visit only, to receive the vaccine and then leave the clinic, so no medical provider saw the patient that day. The medical assistant who gave the vaccine mistakenly gave a Flulaval vaccine instead of a Pediarix vaccine.  This case has been linked to the case US2023031103 reported by the same reporter for same patient.; Sender's Comments:  US-GSK-US2023031103:Same reporter US-GSK-US2023AMR044927:Same reporter / Invalid case
Local fever and mild swelling at injection site with  mild throbbing and redness around site diameter growing from 1 inch to  3 inches.  General tiredness, body aches, on and off for 5 days.
This is a spontaneous report from a contactable consumer via a Pfizer Sales representative. A patient of unspecified age (Age: Over 65; Unit: Unknown) and gender received PREVNAR 13 at single dose, PNEUMOVAX at unknown dose, both with route of administration, therapy date unspecified, single for immunization. The patient's medical history and concomitant medications were not reported. The patient had both vaccines, still got pneumonia and was hospitalized on an unspecified date with outcome of unknown. No follow-up attempts are possible. No further information is expected. Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.
Just about a week after I got my shot, I started to have sinus symptoms. Sinus headache, stuffed up nose. Continued on and got worse over time. Tried Nyquil and OTC sinus medication and those didn't work. I went to the doctor in January because I suddenly started having an earache in my right ear then it went to both ears. When I went to the doctor she put me on ear drops and penicillin. A week later I went back and it didn't get any better so she put me on steroids along with the other medication I was already on. It got a little better and has left the left ear, but the right ear is still bothering me.
Pt was given her first Gardasil shot this morning while sitting on a chair, after less than a minute, the pt passed out and her head twitched for about 5 seconds. She urinated involuntarily and was diaphoretic. Ammonia capsule was placed close to her nose & she regained consciousness. An attempt was made to call 911 but pt is now alert and oriented so call cancelled. The incident lasted for about 30 seconds. Oxygen provided via face mask at 4L/min. Pt is now alert & oriented w no signs of acute distress. After 5 minutes, she passed out again which lasted for about 10 seconds. Pt again is alert and orieneted. VS stable. PERRLA. No signs of acute distress. Pt was brought to exam table to lie down w ice pack behind her neck. Mom at waiting room was called inside. She will be bringing the pt home. Pt & mom denies any allergies. She is advised to see pcp for second Gardasil shot. She left the clinic in a stable condition w no symptoms/complaints. ER warnings given. Asst manager called pt in PM to f/up, no answer.
2 days p/vax leg where recv DTAP was reddened, inflamed & itched;mom stated it had improved from the day before-the inflammation was from the top of the knee to the upper thigh groin area;no tx given
pt recv vax 230PM & 6PM went to sleep 6:48PM-woke up screaming when touched rt leg screamed more;lt thigh up to diaper level looked swollen & inflamed;inj site oozing;felt hot - temp not taken;given APAP w/some relief;2AU96 some tenderness
Shingles came about 6 weeks after injection then 10 weeks later I had numbness in extremities.  Hospitalized for 5 days and then diagnoses with Multiple Sclerosis after MRI's and lumbar puncture.  Many cervical and brain lesions discovered.
Swelling; This is a spontaneous report from a contactable consumer(patient). A 75-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: not reported) via unspecified route of administration on arm left at a single dose on 26Jan2021 15:00 for COVID-19 immunization. Medical history was not reported. Patient had no known allergies. Patient received lisinopril(LISINOPRIL) as concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with Covid -19 prior to vaccination. The patient tested for Covid-19 post vaccination. On 27Jan2021 patient experienced swelling that still hasn't gone down. No other adverse effects at all. Not painful. On 28Feb2021 patient had nasal swab resulted negative. Patient didn't received treatment for the event. The outcome of event was not recovered.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Injection site reaction. Redness 2 inch in diameter, pain, warm to the touch. Pt also says Blood sugar had increased significantly since getting shot.
10-15-07 - Flu Shot - High School; 10-16-07 - Loss of strength in right arm, fingers tingly; 10-17-07 - Arm very achey. Went to Primary Care Doctor. If not better would make referral; 10-18-07 - Saw neurologist; 11-7-07 - EMG - neuralgic amypotrophy Parsonage Turner - Arm, shoulder hand, fingers right chest; EMG - 11-8-07 - Parsonage-Turner
After receiving Tdap,IPV, Varicella & HepB(in that order)child bcame pale & fainted. Episode lasted approx 5 seconds-with child responding, alert & oriented.BP-90/60; Pulse-60. After 15 minutes: BP 90/60; Pulse 66. Child stated that she looked @ needle & felt "funny".
Rash started on feet and then worked its way up her body to trunk.  Patient visited local urgent care who diagnosed adverse reaction to Zostavax and initiated Medrol Dosepak course.
covered in rash from head to toe had temp w/in first 24 hrs; did not take temp; (no reaction to first set of shots); rash looks like heat rash; is not itching;
On April 18 I developed a headache and fever (101), fatigue, tightness/pressure in my throat/esophagus.  Continued through April 20, when I called my GI physician to describe symptoms.  Doctor recommended going to Urgent Care to be tested for COVID 19.   Within an hour or two I went for the test, which was negative.  The attending doctor then ordered EKG, blood tests, and CT scan to see what was going on.  Found high white blood cell count and Pericardial Effusion.  Sent me to hospital, where I was admitted and spent 6 days.  The diagnosis was that the Pericardial Effusion was caused by inflammation, not infection, and I was started on a combination of drugs to eliminate the fluid.  I was released on April 26 with only trace fluid around my heart.
I had my vaccination on 05/09/2022. On 06/01/2022 I had a stroke. I was taken to the emergency room. I was given a blood panel in which the platelets were shown to be decreasing. I had had the second stroke in a year. I was in the hospital for 10 days.
RN administered Moderna vaccine to a non-employee/non patient individual that is only 16 y.o.  on 4/7/28 at 6:40 PM IM Lt arm.  RN discovered age upon reviewing consent after vaccination was administered. Individual stayed for a duration of 20 minutes without adverse reaction noted.  Mom was also with son during vaccination.
I did not have any symptoms with the vaccine. I tested positive for Covid 19 on 5/14/2022. I started feeling symptoms 5/12 with a sore throat and congestion. On the 14th I had a fever, ran 100 to 101 for a couple of days. I do not recall taking anything for symptoms prior to going to pharmacy clinic. They prescribed PAXLOVID, Z-PAK, prescription cough medication and inhaler (I had a fluid in my lungs). I was really sick for five days and slowly started to feel better.
tested positive for covid on binax rapid antigen test 11/29/22- asymptomatic, tested as f/u to known exposure
patient felt lightheaded and dizzy 10 minutes after vaccine, passed out, came through and had emesis for about 20 minutes
Pt reports swelling and slight itching at site of injection 2 days after receiving injection. Pt states it was worse yesterday w/ mild improvement today. Will provide rx for ibuprofen, BENADRYL PRN swelling, itching.
after shot, left arm became sore and tight at site of injection. The day after injection, arm became significantly more swollen and hot to the touch. site became very sore. Day 3, site is still swollen, but has gone down. site still warm to the touch.
ringing in ears,; fat lips, fat throat, fat tongue,  Benadryl at 1540;  symptom resolved.
hives covering entire body; really really intense reaction; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction). At the time of the report, URTICARIA (hives covering entire body) and VACCINATION COMPLICATION (really really intense reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-406162 (Patient Link).